Variant report
Variant | nsv819394 |
---|---|
Chromosome Location | chr1:62112241-62119526 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr1:62112891-62113154 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr1:62113772-62113972 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr1:62113754-62113947 | K562 | blood: | n/a | n/a |
4 | CTCF | chr1:62118629-62118661 | Spleen_OC | spleen: | n/a | n/a |
5 | FOXA1 | chr1:62112832-62113155 | HepG2 | liver: | n/a | chr1:62113019-62113034 |
6 | FOXA1 | chr1:62112873-62113092 | HepG2 | liver: | n/a | chr1:62113019-62113034 |
7 | FOXA1 | chr1:62116322-62116620 | T-47D | breast: | n/a | n/a |
8 | FOXA1 | chr1:62112903-62113098 | HepG2 | liver: | n/a | chr1:62113019-62113034 |
9 | FOXA1 | chr1:62112882-62113105 | HepG2 | liver: | n/a | chr1:62113019-62113034 |
10 | FOXA1 | chr1:62116307-62116558 | T-47D | breast: | n/a | n/a |
11 | FOXA2 | chr1:62112881-62113100 | HepG2 | liver: | n/a | n/a |
12 | GATA3 | chr1:62116259-62116598 | T-47D | breast: | n/a | n/a |
13 | GATA3 | chr1:62116359-62116578 | T-47D | breast: | n/a | n/a |
14 | POLR2A | chr1:62117975-62118015 | ProgFib | skin: | n/a | n/a |
15 | RCOR1 | chr1:62118152-62118191 | K562 | blood: | n/a | n/a |
16 | SPI1 | chr1:62114351-62114789 | HL-60 | blood: | n/a | n/a |
17 | UBTF | chr1:62114417-62114490 | K562 | blood: | n/a | n/a |
18 | ZKSCAN1 | chr1:62113790-62114420 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-INADL-1 | chr1:62113728-62113990 | XLOC_000227 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223920 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139063027 | chr1:62112241-62112242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372758987 | chr1:62112243-62112244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185031927 | chr1:62112279-62112280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190274431 | chr1:62112289-62112290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139543188 | chr1:62112483-62112484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557279074 | chr1:62112487-62112488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574852070 | chr1:62112527-62112528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555652590 | chr1:62112553-62112554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545786015 | chr1:62112593-62112594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563997115 | chr1:62112616-62112617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573888453 | chr1:62112641-62112642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373936941 | chr1:62112677-62112678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369068355 | chr1:62112682-62112683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544476602 | chr1:62112699-62112700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7551993 | chr1:62112740-62112741 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs74076280 | chr1:62112744-62112745 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs376326661 | chr1:62112747-62112748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12092067 | chr1:62112763-62112764 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs536075835 | chr1:62112883-62112884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527899981 | chr1:62112903-62112904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192535812 | chr1:62112928-62112929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561509483 | chr1:62112978-62112979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531959515 | chr1:62112987-62112988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550441251 | chr1:62113063-62113064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565289740 | chr1:62113080-62113081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532502925 | chr1:62113093-62113094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547935833 | chr1:62113095-62113096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566146530 | chr1:62113097-62113098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7544197 | chr1:62113102-62113103 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs368109820 | chr1:62113131-62113132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs398102776 | chr1:62113132-62113133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34083756 | chr1:62113133-62113134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs397693049 | chr1:62113140-62113141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17378118 | chr1:62113261-62113262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537756995 | chr1:62113402-62113403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550882468 | chr1:62113425-62113426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10889247 | chr1:62113442-62113443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577238051 | chr1:62113443-62113444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553234814 | chr1:62113457-62113458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs80245753 | chr1:62113465-62113466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150508798 | chr1:62113484-62113485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139486146 | chr1:62113498-62113499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368361420 | chr1:62113532-62113533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533416704 | chr1:62113550-62113551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150051837 | chr1:62113555-62113556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576540310 | chr1:62113569-62113570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12142692 | chr1:62113597-62113598 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs569674820 | chr1:62113628-62113629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565552105 | chr1:62113648-62113649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532568218 | chr1:62113649-62113650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Breast cancer | 16620391 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
CNS Malformation Syndrome | 17530927 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:62103400-62146400 | Weak transcription | Gastric | stomach |
2 | chr1:62108000-62112800 | Weak transcription | Ovary | ovary |
3 | chr1:62108600-62112400 | Weak transcription | Stomach Mucosa | stomach |
4 | chr1:62112400-62113000 | Enhancers | Stomach Mucosa | stomach |
5 | chr1:62112600-62113000 | Enhancers | HepG2 | liver |
6 | chr1:62112800-62113000 | Enhancers | Ovary | ovary |
7 | chr1:62114400-62115000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr1:62117800-62118200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr1:62117800-62118400 | Enhancers | Primary hematopoietic stem cells | blood |